$0.00
(+0.00%
) Quote detailsUSD
+$0.00
(+0.00%
)At Close (As of Oct 20, 2025)
$1.43B
Market Cap
3.647
P/E Ratio
2.41
EPS
$11.55
52 Week High
$5.01
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Novavax, Inc. is a biotechnology company headquartered in Gaithersburg, Maryland, that specializes in the research and development of innovative vaccines targeting serious infectious diseases. Leveraging its proprietary protein-based nanoparticle technology, Novavax has cultivated a robust pipeline, notably including its advanced COVID-19 vaccine candidate, which has received considerable attention amid the ongoing global health crisis. The company's commitment to addressing pressing public health needs and its strategic partnerships position it as a formidable contender in the biotechnology arena, making it an appealing investment opportunity for institutional investors aiming to support transformative health solutions.